尿激酶静脉溶栓治疗急性心肌梗死90例疗效分析  

Clinical Effect of Intravenous Infusion of Urokinase in 90 Patients with Acute Myocardial Infarction

作　　者：朱海玲[1] 

机构地区：[1]河南油田总医院,南阳473132

出　　处：《中国临床医学》2003年第4期521-522,共2页Chinese Journal of Clinical Medicine

摘　　要：目的 :对尿激酶静脉溶栓治疗急性心肌梗死 90例进行疗效分析。方法 :在冠心病监护病房行静脉溶栓治疗。结果 :冠脉再通率 6 0 % ,4周住院病死率 6 .6 7%。结论 :再通组并发症发生率明显低于未再通组 ,早期溶栓治疗对合并心力衰竭或心源性休克的急性心肌梗死患者也有效 ,除 2例发生轻微出血外 ,未见其他严重不良反应。Objective: To observe the therapeutic effect and safety of intravenous infusion of urokinase with acute myocardial infarction(AMI). Methods: Ninety patients with AMI were treated by intravenous infusion of urokinase in CCU. Results: The reperfusion rate was 60%,the fatality rate of four weeks in-patient was 6.67%. Conclusion: The complication of reperfusion group were much lower than that of no reperfusion group.The earlier thrombolytic therapy in AMI patients complicated cardiac failure or cardiogenic shock is effective and safe,no other severe side effects were found except two patients had a little blood loss.

关 键 词：尿激酶 静脉溶栓 急性心肌梗死 心力衰竭 心源性休克 

分 类 号：R542.22[医药卫生—心血管疾病] R977.3[医药卫生—内科学]